News Summary

Baxter Canada has introduced the Volara oscillation and lung expansion therapy system to the Canadian healthcare market, providing significant benefits for respiratory patients. The Volara system, initially launched in the U.S. in 2020, is now being used at the Southern Alberta Adult Cystic Fibrosis Clinic, part of the University of Calgary. The system offers a more efficient alternative to traditional manual techniques, reducing treatment time and patient fatigue. It features a digital touchscreen for customizable treatments and an integrated nebulizer for medication delivery. The system is anticipated to expand its usage to other respiratory conditions and patient populations, potentially reducing hospital stays and healthcare costs. With increasing air quality issues and an aging population, Baxter’s Volara system aims to address the growing need for effective respiratory care in Canada.